Get started

Medical

THYROCARE recently turned trend, about to test resistance zone.Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves. You can also see: There is still rooms for the Williams 224 to climb further. The historical volatility is lower than it was in November indicating a more stable trend. The Ichimoku is agreeing with the recent trend turn. There is possibility that the MACD will turn down across its signal but I believe that it will either skirt the signal and then continue rising or pass below it momentarily as the current Elliott Correction Wave plays out. It should be noted that the fundamentals of THYROCARE are absolutely excellent and therefore could be worth holding not only for the immediate future. Thank you. Please if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods. This does not constitute financial advice. Any prices, even if explicitly stated, are presented with intent to discuss the symbol and potential interpretations. Any trades shown or mentioned are examples and neither recommendations or mandates.
NSE:THYROCARELong
by Kabeldon
HAPP just finished Elliott Correction Wave, Impulse incoming?Hi. In this 1D chart I've plotted the Elliott Wave patterns from the latest months and from it concluded that the next wave will be an impulse wave, as a clear correction wave has just finished. The size of the incoming impulse is of course subject to speculation, but the certainty of it is substantial according to my analys of the latest patterns. Thank you. Please if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods. This does not constitute financial advice. Any prices, even if explicitly stated, are presented with intent to discuss the symbol and potential interpretations. Any trades shown or mentioned are examples and neither recommendations or mandates .
HLong
by Kabeldon
EARS Long Swing-Trade IdeaThe rising reverse wedge pattern highlights common lower support and higher resistance trend. A pattern has emerged where the price appears to spike on/around the 9th and 21st of the month and the price seems to rise up to the next level of the fibonacci retracement (Support/Resistance). I would consider taking a long position at the $3.50 level for a potential move up to $6.00 by 22/Mar/2021. The fibonacci retracement levels are derived from a previous high volume price spike event that occurred on 1/Dec/2020 wherein the highest concentration of volume occurred at the $5.14 - 5.61 price range. It is probable that a high number of investors are locked in within that price range and may induce more sellers at these levels, thus there will be significant resistance to pass through that price range on the next spike. $6.00 is possible, but $5.50 may be a more realistic price target due to resistance. I currently have no position in EARS, so this is just my unbiased opinion based on previous stock performance.
ELong
by khollspati
3
APHA Day Trade IdeaAPHA (Aphria, Inc.) is rebounding up from a support line on the year to date rising fibonacci channel. It is probable that APHA will continue it's upward momentum up to 17.81 for an approximate 13% gain (+/-) upon where it would encounter the yearly 61.8% fibonacci resistance level. If APHA crosses above 17.81, the Point of control (POC) where volume is most concentrated is at 18.75. Crossing this level is less probable but not impossible, as APHA has been known to out perform both in market hours and after hours. I currently have no position in APHA, so this is just my unbiased opinion.
ALong
by khollspati
ZOMZomedica looks like it will be a winner once its veterinarian office lab testing product launches on March 30 . ZOM stock is already up 850% so far this year. In fact, it peaked at $2.70 in early February in anticipation of this product launch.Moreover, the company has very smart about taking advantage of its huge price spike. On Feb. 8, it raised another $185.4 million. In fact, as of Feb. 26, Zomedica had an astounding $277.5 million in cash on its balance sheet, based on an 8-K filing
ZShort
by roclub1
7
In search for the next NAKD Naked Brand? Volume play!Can you see some volume patterns? This was my first NAKD Naked Brand post: GBT Researching AI based, Robotics Technology for the Medical Field GBT Researching a Development of a Radio Based Computer Vision System For Cardiovascular Applications GBT Tokenize Corp Evaluating qTerm Applications for Hotel Industry GBT Developing a Long-Range Radio System Targeting Global Communication for Remote Telemedicine (globenewswire.com) AI Eye Podcast: GBT Technologies' CTO Discusses the Significance of FDA Approval for the qTerm Human Vital Signs Device. (newsfilecorp.com) Fell free to Join my Patreon group in the description of this idea!
OTC:GTCHLong
by TopgOptions
26
867 China Medical Systems Breakout / Long IdeaHello Tradingviewians, CMS has been in a long consolidation to digest lowering growth rates. Additionally it has been under fire by short sellers, alleging CMS of faking revenue numbers. Should the numbers be genuine, and factors like consistent insider buying suggest it, CMS represents serious value at this point. Technically, a two year downtrend collides with the support line of the superordinate uptrend. Should ladder win, a short squeeze may follow to previous interim highs. After a phase of returning confidence, all time highs could be reached again. This is my first published technically supported investment idea. Let me know what you think. Thanks! BR
HKEX:867Long
by UI00